Skip to main content

05.04.2024 | Narrative review

Critical care management of acute liver failure

verfasst von: Surender Singh Sehrawat, Madhumita Premkumar

Erschienen in: Indian Journal of Gastroenterology

Einloggen, um Zugang zu erhalten

Abstract

The management of acute liver failure (ALF) in modern hepatology intensive care units (ICU) has improved patient outcomes. Critical care management of hepatic encephalopathy, cerebral edema, fluid and electrolytes; prevention of infections and organ support are central to improved outcomes of ALF. In particular, the pathogenesis of encephalopathy is multifactorial, with ammonia, elevated intra-cranial pressure and systemic inflammation playing a central role. Although ALF remains associated with high mortality, the availability of supportive care, including organ failure support such as plasma exchange, timely mechanical ventilation or continuous renal replacement therapy, either conservatively manages patients with ALF or offers bridging therapy until liver transplantation. Thus, appropriate critical care management has improved the likelihood of patient recovery in ALF. ICU care interventions such as monitoring of cerebral edema, fluid status assessment and interventions for sepsis prevention, nutritional support and management of electrolytes can salvage a substantial proportion of patients. In this review, we discuss the key aspects of critical care management of ALF.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;, Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;, Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.
2.
Zurück zum Zitat Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.PubMedPubMedCentralCrossRef Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97. Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97.
4.
Zurück zum Zitat Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129–36.PubMedCrossRef Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129–36.PubMedCrossRef
5.
Zurück zum Zitat Tandon BN, Bernauau J, O’Grady J, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.PubMedCrossRef Tandon BN, Bernauau J, O’Grady J, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.PubMedCrossRef
6.
Zurück zum Zitat Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38:6–14.PubMedCrossRef Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38:6–14.PubMedCrossRef
9.
10.
Zurück zum Zitat Rao A, Rule JA, Cerro-Chiang G, et al. Role of hepatitis c infection in acute liver injury/acute liver failure in North America. Dig Dis Sci. 2023;68:304–11.PubMedCrossRef Rao A, Rule JA, Cerro-Chiang G, et al. Role of hepatitis c infection in acute liver injury/acute liver failure in North America. Dig Dis Sci. 2023;68:304–11.PubMedCrossRef
11.
Zurück zum Zitat Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Diagnosis and management of hepatitis delta virus infection. Dig Dis Sci. 2023;68:3237–48.PubMedPubMedCentralCrossRef Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Diagnosis and management of hepatitis delta virus infection. Dig Dis Sci. 2023;68:3237–48.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Gupta E, Ballani N, Kumar M, Sarin SK. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults. Indian J Gastroenterol. 2015;34:448–52.PubMedCrossRef Gupta E, Ballani N, Kumar M, Sarin SK. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults. Indian J Gastroenterol. 2015;34:448–52.PubMedCrossRef
13.
Zurück zum Zitat Rabaan AA, Bakhrebah MA, Nassar MS, et al. Suspected adenovirus causing an emerging HEPATITIS among children below 10 years: a review. Pathogens. 2022;11:712.PubMedPubMedCentralCrossRef Rabaan AA, Bakhrebah MA, Nassar MS, et al. Suspected adenovirus causing an emerging HEPATITIS among children below 10 years: a review. Pathogens. 2022;11:712.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Mellinger JL, Rossaro L, Naugler WE, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci. 2014;59:1630–7.PubMedPubMedCentralCrossRef Mellinger JL, Rossaro L, Naugler WE, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci. 2014;59:1630–7.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Archer JS. Acute liver failure in pregnancy. A case report. J Reprod Med. 2001;46:137–40.PubMed Archer JS. Acute liver failure in pregnancy. A case report. J Reprod Med. 2001;46:137–40.PubMed
16.
17.
Zurück zum Zitat Song ATW, Carneiro D’Albuquerque LA. Acute liver failure secondary to yellow fever: a challenging scenario. Clin Liver Dis (Hoboken). 2019;13:58–61.PubMedPubMedCentralCrossRef Song ATW, Carneiro D’Albuquerque LA. Acute liver failure secondary to yellow fever: a challenging scenario. Clin Liver Dis (Hoboken). 2019;13:58–61.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.PubMedCrossRef Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.PubMedCrossRef
22.
Zurück zum Zitat Karvellas CJ, Stravitz RT. Acute liver failure. In: Arun J. Sanyal TDB, Norah A, Terrault, Keith D, Lindor, editors. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. 7th ed. Philadelphia, PA: Elsevier; 2018. p. 19103–2899. Karvellas CJ, Stravitz RT. Acute liver failure. In: Arun J. Sanyal TDB, Norah A, Terrault, Keith D, Lindor, editors. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. 7th ed. Philadelphia, PA: Elsevier; 2018. p. 19103–2899.
23.
Zurück zum Zitat Eapen CE, Venkataraman J. Rodenticide (yellow phosphorus poison)-induced hepatotoxicity in India: constraints during management. J Clin Exp Hepatol. 2021;11:414–7.PubMedPubMedCentralCrossRef Eapen CE, Venkataraman J. Rodenticide (yellow phosphorus poison)-induced hepatotoxicity in India: constraints during management. J Clin Exp Hepatol. 2021;11:414–7.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides poisoning. Int J Hepatol. 2012;2012:487480. Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides poisoning. Int J Hepatol. 2012;2012:487480.
25.
Zurück zum Zitat Phan T, Desmond C. Hepatitis E infection with acute liver failure. ACG Case Rep J. 2020;7:e00361. Phan T, Desmond C. Hepatitis E infection with acute liver failure. ACG Case Rep J. 2020;7:e00361.
26.
Zurück zum Zitat Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.PubMedPubMedCentralCrossRef Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Casey LC, Fontana RJ, Aday A, et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy related? Hepatology. 2020;72:1366–77. Casey LC, Fontana RJ, Aday A, et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy related? Hepatology. 2020;72:1366–77.
28.
Zurück zum Zitat De Martin E, Coilly A, Houssel-Debry P, et al. Treatment and prognosis of acute severe autoimmune hepatitis. J Hepatology. 2017;1:S4.CrossRef De Martin E, Coilly A, Houssel-Debry P, et al. Treatment and prognosis of acute severe autoimmune hepatitis. J Hepatology. 2017;1:S4.CrossRef
29.
Zurück zum Zitat Seetharam A. Intensive care management of acute liver failure: considerations while awaiting liver transplantation. J Clin Translation Hepatol. 2019;7:384. Seetharam A. Intensive care management of acute liver failure: considerations while awaiting liver transplantation. J Clin Translation Hepatol. 2019;7:384.
31.
Zurück zum Zitat Montrief T, Koyfman A, Long B. Acute liver failure: a review for emergency physicians. Ame J Emerg Med. 2019;37:329–37.CrossRef Montrief T, Koyfman A, Long B. Acute liver failure: a review for emergency physicians. Ame J Emerg Med. 2019;37:329–37.CrossRef
32.
Zurück zum Zitat O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRef O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRef
33.
Zurück zum Zitat Kumar R, Shalimar, Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut. 2012;61:1068–75. Kumar R, Shalimar, Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut. 2012;61:1068–75.
34.
Zurück zum Zitat Dhiman RK, Jain S, Maheshwari U, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.PubMedCrossRef Dhiman RK, Jain S, Maheshwari U, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.PubMedCrossRef
35.
Zurück zum Zitat Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther. 2010;31:1064–76.PubMedCrossRef Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther. 2010;31:1064–76.PubMedCrossRef
36.
Zurück zum Zitat McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.PubMedCrossRef McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.PubMedCrossRef
37.
Zurück zum Zitat Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789–96.PubMedCrossRef Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789–96.PubMedCrossRef
38.
Zurück zum Zitat Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–51.PubMedCrossRef Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–51.PubMedCrossRef
39.
Zurück zum Zitat Lin CH, Chen CL, Lin TK, Chen NC, Tsai MH, Chuang YC. Levetiracetam in the treatment of epileptic seizures after liver transplantation. Medicine (Baltimore). 2015;94:e1350. Lin CH, Chen CL, Lin TK, Chen NC, Tsai MH, Chuang YC. Levetiracetam in the treatment of epileptic seizures after liver transplantation. Medicine (Baltimore). 2015;94:e1350.
41.
Zurück zum Zitat Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23:625–9.PubMedPubMedCentralCrossRef Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23:625–9.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-64, 64 e1. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-64, 64 e1.
43.
Zurück zum Zitat Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2:43–51.PubMedCrossRef Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2:43–51.PubMedCrossRef
44.
Zurück zum Zitat Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75:2034–9.PubMedCrossRef Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75:2034–9.PubMedCrossRef
45.
Zurück zum Zitat Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6:e2327739. Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6:e2327739.
46.
Zurück zum Zitat Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46:455–62. Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46:455–62.
47.
Zurück zum Zitat Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon. 1993;31:1513–40.PubMedCrossRef Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon. 1993;31:1513–40.PubMedCrossRef
48.
Zurück zum Zitat Fujiwara K, Yasui S, Haga Y, et al. Early combination therapy with corticosteroid and nucleoside analogue induces rapid resolution of inflammation in acute liver failure due to transient hepatitis B virus infection. Intern Med. 2018;57:1543–52. Fujiwara K, Yasui S, Haga Y, et al. Early combination therapy with corticosteroid and nucleoside analogue induces rapid resolution of inflammation in acute liver failure due to transient hepatitis B virus infection. Intern Med. 2018;57:1543–52.
49.
Zurück zum Zitat Goya T, Kurashige T, Kurokawa M, et al. The combination of nucleotide analog therapy and steroid pulse therapy for acute HBV infection effectively promotes HBV clearance. Gastroenterology Insights. 2021;13:1–8.CrossRef Goya T, Kurashige T, Kurokawa M, et al. The combination of nucleotide analog therapy and steroid pulse therapy for acute HBV infection effectively promotes HBV clearance. Gastroenterology Insights. 2021;13:1–8.CrossRef
50.
Zurück zum Zitat Ichai P, Roque Afonso AM, Sebagh M, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl. 2005;11:1550–5.PubMedCrossRef Ichai P, Roque Afonso AM, Sebagh M, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl. 2005;11:1550–5.PubMedCrossRef
51.
Zurück zum Zitat Karkhanis J, Verna EC, Chang MS, et al. Steroid use in acute liver failure. Hepatology. 2014;59:612–21.PubMedCrossRef Karkhanis J, Verna EC, Chang MS, et al. Steroid use in acute liver failure. Hepatology. 2014;59:612–21.PubMedCrossRef
52.
Zurück zum Zitat Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson’s disease. Liver Transpl. 2002;8:962–7.PubMedCrossRef Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson’s disease. Liver Transpl. 2002;8:962–7.PubMedCrossRef
53.
Zurück zum Zitat Pham HP, Schwartz J, Cooling L, et al. Report of the ASFA apheresis registry study on Wilson’s disease. J Clin Apher. 2016;31:11–5.PubMedCrossRef Pham HP, Schwartz J, Cooling L, et al. Report of the ASFA apheresis registry study on Wilson’s disease. J Clin Apher. 2016;31:11–5.PubMedCrossRef
54.
Zurück zum Zitat Abolfazl Avan HRK, Tjaard U Hoogenraad. Initial zinc therapy in Wilson’s disease with acute liver failure and copper intoxication: a clinical observation. Abstracts of the Seventeenth International Congress of Parkinson’s Disease and Movement Disorders: Movement Disorder; 2–13. Abolfazl Avan HRK, Tjaard U Hoogenraad. Initial zinc therapy in Wilson’s disease with acute liver failure and copper intoxication: a clinical observation. Abstracts of the Seventeenth International Congress of Parkinson’s Disease and Movement Disorders: Movement Disorder; 2–13.
55.
Zurück zum Zitat Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: a systematic analysis. Int J Infect Dis. 2019;84S:S68–73.PubMedCrossRef Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: a systematic analysis. Int J Infect Dis. 2019;84S:S68–73.PubMedCrossRef
56.
57.
Zurück zum Zitat John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10:e0004616. John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10:e0004616.
58.
Zurück zum Zitat Moola S, Beri D, Salam A, Jagnoor J, Teja A, Bhaumik S. Leptospirosis prevalence and risk factors in India: evidence gap maps. Trop Doct. 2021;51:415–21.PubMedCrossRef Moola S, Beri D, Salam A, Jagnoor J, Teja A, Bhaumik S. Leptospirosis prevalence and risk factors in India: evidence gap maps. Trop Doct. 2021;51:415–21.PubMedCrossRef
59.
Zurück zum Zitat Anand AC, Garg HK. Approach to clinical syndrome of jaundice and encephalopathy in tropics. J Clin Exp Hepatol. 2015;5 Suppl 1:S116–30. Anand AC, Garg HK. Approach to clinical syndrome of jaundice and encephalopathy in tropics. J Clin Exp Hepatol. 2015;5 Suppl 1:S116–30.
60.
Zurück zum Zitat Reynolds AS, Brush B, Schiano TD, Reilly KJ, Dangayach NS. Neurological monitoring in acute liver failure. Hepatology. 2019;70:1830–5.PubMedCrossRef Reynolds AS, Brush B, Schiano TD, Reilly KJ, Dangayach NS. Neurological monitoring in acute liver failure. Hepatology. 2019;70:1830–5.PubMedCrossRef
61.
Zurück zum Zitat Chen JW, Gombart ZJ, Rogers S, Gardiner SK, Cecil S, Bullock RM. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the Neurological Pupil index. Surg Neurol Int. 2011;2:82. Chen JW, Gombart ZJ, Rogers S, Gardiner SK, Cecil S, Bullock RM. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the Neurological Pupil index. Surg Neurol Int. 2011;2:82.
62.
Zurück zum Zitat Vijay P, Lal BB, Sood V, Khanna R, Patidar Y, Alam S. Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure. Hepatol Int. 2021;15:502–9.PubMedCrossRef Vijay P, Lal BB, Sood V, Khanna R, Patidar Y, Alam S. Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure. Hepatol Int. 2021;15:502–9.PubMedCrossRef
63.
Zurück zum Zitat Bhardwaj A, Bhagat H, Grover VK. Jugular venous oximetry. J Neuroanaesthesiol Critical Care. 2015;2:225–31.CrossRef Bhardwaj A, Bhagat H, Grover VK. Jugular venous oximetry. J Neuroanaesthesiol Critical Care. 2015;2:225–31.CrossRef
64.
Zurück zum Zitat Paschoal FM Jr, Nogueira RC, Ronconi Kde A, de Lima OM, Teixeira MJ, Bor-Seng-Shu E. Multimodal brain monitoring in fulminant hepatic failure. World J Hepatol. 2016;8:915–23. Paschoal FM Jr, Nogueira RC, Ronconi Kde A, de Lima OM, Teixeira MJ, Bor-Seng-Shu E. Multimodal brain monitoring in fulminant hepatic failure. World J Hepatol. 2016;8:915–23.
65.
Zurück zum Zitat Hwang S, Lee SG, Park JI, et al. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91–7.PubMedCrossRef Hwang S, Lee SG, Park JI, et al. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91–7.PubMedCrossRef
67.
Zurück zum Zitat Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care. 2018;29:280–90.PubMedCrossRef Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care. 2018;29:280–90.PubMedCrossRef
68.
Zurück zum Zitat Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging. 2010;34:327–31.PubMedCrossRef Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging. 2010;34:327–31.PubMedCrossRef
69.
Zurück zum Zitat Picard B, Sigaut S, Roux O, et al. Evaluation of transcranial Doppler use in patients with acute liver failure listed for emergency liver transplantation. Clin Transplant. 2023;37:e14975. Picard B, Sigaut S, Roux O, et al. Evaluation of transcranial Doppler use in patients with acute liver failure listed for emergency liver transplantation. Clin Transplant. 2023;37:e14975.
70.
Zurück zum Zitat Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14:e24915. Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14:e24915.
71.
Zurück zum Zitat Richards E, Munakomi S, Mathew D. Optic Nerve Sheath Ultrasound. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Richards E, Munakomi S, Mathew D. Optic Nerve Sheath Ultrasound. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
72.
Zurück zum Zitat Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure–a controlled clinical trial. J Hepatol. 2004;41:89–96.PubMedCrossRef Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure–a controlled clinical trial. J Hepatol. 2004;41:89–96.PubMedCrossRef
73.
Zurück zum Zitat Benedetti GM, Guerriero RM, Press CA. Review of noninvasive neuromonitoring modalities in children II: EEG, qEEG. Neurocrit Care. 2023;39:618–38.PubMedCrossRef Benedetti GM, Guerriero RM, Press CA. Review of noninvasive neuromonitoring modalities in children II: EEG, qEEG. Neurocrit Care. 2023;39:618–38.PubMedCrossRef
74.
Zurück zum Zitat Deep A, Alexander EC, Bulut Y, et al. Advances in medical management of acute liver failure in children: promoting native liver survival. Lancet Child Adolesc Health. 2022;6:725–37.PubMedCrossRef Deep A, Alexander EC, Bulut Y, et al. Advances in medical management of acute liver failure in children: promoting native liver survival. Lancet Child Adolesc Health. 2022;6:725–37.PubMedCrossRef
75.
Zurück zum Zitat Newey CR, Sarwal A, Hantus S. Continuous electroencephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care. 2013;18:261–5.PubMedCrossRef Newey CR, Sarwal A, Hantus S. Continuous electroencephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care. 2013;18:261–5.PubMedCrossRef
76.
Zurück zum Zitat Hussain E, Grimason M, Goldstein J, et al. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014;58:449–56.PubMedCrossRef Hussain E, Grimason M, Goldstein J, et al. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014;58:449–56.PubMedCrossRef
77.
Zurück zum Zitat Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis. 2005;20:181–92.PubMedCrossRef Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis. 2005;20:181–92.PubMedCrossRef
78.
Zurück zum Zitat Chavarria L, Alonso J, Rovira A, Cordoba J. Neuroimaging in acute liver failure. Neurochem Int. 2011;59:1175–80.PubMedCrossRef Chavarria L, Alonso J, Rovira A, Cordoba J. Neuroimaging in acute liver failure. Neurochem Int. 2011;59:1175–80.PubMedCrossRef
79.
Zurück zum Zitat Jadaun SS, Sharma S, Madhusudhan KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure. J Clin Exp Hepatol. 2022;12:343–52.PubMedCrossRef Jadaun SS, Sharma S, Madhusudhan KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure. J Clin Exp Hepatol. 2022;12:343–52.PubMedCrossRef
80.
Zurück zum Zitat Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528–33.PubMedPubMedCentralCrossRef Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528–33.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Vilela P, Rowley HA. Brain ischemia: CT and MRI techniques in acute ischemic stroke. Eur J Radio. 2017;96:162–72.CrossRef Vilela P, Rowley HA. Brain ischemia: CT and MRI techniques in acute ischemic stroke. Eur J Radio. 2017;96:162–72.CrossRef
83.
Zurück zum Zitat Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.PubMedCrossRef Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.PubMedCrossRef
84.
Zurück zum Zitat Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–52.PubMedCrossRef Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–52.PubMedCrossRef
85.
Zurück zum Zitat Jayalakshmi VT, Bernal W. Update on the management of acute liver failure. Curr Opin Crit Care. 2020;26:163–70.PubMedCrossRef Jayalakshmi VT, Bernal W. Update on the management of acute liver failure. Curr Opin Crit Care. 2020;26:163–70.PubMedCrossRef
86.
Zurück zum Zitat Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001;56:1746–8.PubMedCrossRef Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001;56:1746–8.PubMedCrossRef
87.
Zurück zum Zitat Kalal CR, Maiwall R, Choudhary A, et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial. Dig Dis. 2022;40:607–15.PubMedCrossRef Kalal CR, Maiwall R, Choudhary A, et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial. Dig Dis. 2022;40:607–15.PubMedCrossRef
88.
Zurück zum Zitat de Lacerda GCB. Treating seizures in renal and hepatic failure. J Epilepsy Clin Neurophysiol. 2008;14Suppl2:46–50. de Lacerda GCB. Treating seizures in renal and hepatic failure. J Epilepsy Clin Neurophysiol. 2008;14Suppl2:46–50.
89.
Zurück zum Zitat Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220–2.PubMedCrossRef Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220–2.PubMedCrossRef
90.
Zurück zum Zitat Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188–93.PubMedCrossRef Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188–93.PubMedCrossRef
91.
Zurück zum Zitat Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000;31:30–4.PubMedCrossRef Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000;31:30–4.PubMedCrossRef
92.
Zurück zum Zitat Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20. Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20.
93.
Zurück zum Zitat Kumar R, Shalimar, Sharma H, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10:925–31. Kumar R, Shalimar, Sharma H, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10:925–31.
94.
Zurück zum Zitat Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136:2159–68.PubMedCrossRef Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136:2159–68.PubMedCrossRef
95.
Zurück zum Zitat Alba L, Hay J, Angulo P, Lee W. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33.CrossRef Alba L, Hay J, Angulo P, Lee W. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33.CrossRef
97.
Zurück zum Zitat Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003:CD001939. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003:CD001939.
98.
Zurück zum Zitat Abenavoli L, Maurizi V, Boccuto L, et al. Nutritional support in acute liver failure. Diseases. 2022;10:108. Abenavoli L, Maurizi V, Boccuto L, et al. Nutritional support in acute liver failure. Diseases. 2022;10:108.
99.
Zurück zum Zitat Belanger-Quintana A, Arrieta Blanco F, Barrio-Carreras D, et al. Recommendations for the diagnosis and therapeutic management of hyperammonaemia in paediatric and adult patients. Nutrients. 2022;14:2755. Belanger-Quintana A, Arrieta Blanco F, Barrio-Carreras D, et al. Recommendations for the diagnosis and therapeutic management of hyperammonaemia in paediatric and adult patients. Nutrients. 2022;14:2755.
100.
Zurück zum Zitat Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542–53.PubMedCrossRef Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542–53.PubMedCrossRef
101.
Zurück zum Zitat Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64:69–78.PubMedCrossRef Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64:69–78.PubMedCrossRef
102.
Zurück zum Zitat Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S. Point-of-care echocardiography and hemodynamic monitoring in cirrhosis and acute-on-chronic liver failure in the COVID-19 era. J Intensive Care Med. 2021;36:511–23.PubMedCrossRef Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S. Point-of-care echocardiography and hemodynamic monitoring in cirrhosis and acute-on-chronic liver failure in the COVID-19 era. J Intensive Care Med. 2021;36:511–23.PubMedCrossRef
103.
Zurück zum Zitat van Limmen J, Iturriagagoitia X, Verougstraete M, et al. Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study. BMC Anesthesiol. 2022;22:202. van Limmen J, Iturriagagoitia X, Verougstraete M, et al. Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study. BMC Anesthesiol. 2022;22:202.
104.
Zurück zum Zitat Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47:381–6.PubMedCrossRef Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47:381–6.PubMedCrossRef
105.
Zurück zum Zitat Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology. 2004;39:471–5.PubMedCrossRef Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology. 2004;39:471–5.PubMedCrossRef
106.
Zurück zum Zitat Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71–7.PubMedCrossRef Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71–7.PubMedCrossRef
107.
Zurück zum Zitat Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-84. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-84.
108.
Zurück zum Zitat Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.PubMedCrossRef Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.PubMedCrossRef
109.
Zurück zum Zitat Moore K. Renal failure in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:967–75.PubMedCrossRef Moore K. Renal failure in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:967–75.PubMedCrossRef
110.
Zurück zum Zitat Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.PubMedCrossRef Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.PubMedCrossRef
111.
Zurück zum Zitat Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21:328–38.PubMedCrossRef Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21:328–38.PubMedCrossRef
112.
Zurück zum Zitat Kappus MR. Acute hepatic failure and nutrition. Nutr Clin Pract. 2020;35:30–5.CrossRef Kappus MR. Acute hepatic failure and nutrition. Nutr Clin Pract. 2020;35:30–5.CrossRef
113.
Zurück zum Zitat Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. British J Clin Pharmacol. 2011;71:20–8.CrossRef Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. British J Clin Pharmacol. 2011;71:20–8.CrossRef
114.
Zurück zum Zitat Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5 Suppl 1:S104–15. Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5 Suppl 1:S104–15.
115.
Zurück zum Zitat Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol. 2013;7:701–12.PubMedCrossRef Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol. 2013;7:701–12.PubMedCrossRef
116.
Zurück zum Zitat Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203. Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203.
117.
Zurück zum Zitat Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52 Suppl 7:vii1-vii12. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52 Suppl 7:vii1-vii12.
118.
Zurück zum Zitat Baquerizo A, Anselmo D, Shackleton C, et al. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation. 2003;75:2007–14.PubMedCrossRef Baquerizo A, Anselmo D, Shackleton C, et al. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation. 2003;75:2007–14.PubMedCrossRef
120.
Zurück zum Zitat Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 2006;44:34–43.PubMedCrossRef Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 2006;44:34–43.PubMedCrossRef
121.
Zurück zum Zitat Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12:1–9.PubMedCrossRef Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12:1–9.PubMedCrossRef
123.
Zurück zum Zitat Kaur P, Verma N, Valsan A, et al. Prevalence, risk factors, and impact of bacterial or fungal infections in acute liver failure patients from India. Dig Dis Sci. 2023;68:4022–38.PubMedCrossRef Kaur P, Verma N, Valsan A, et al. Prevalence, risk factors, and impact of bacterial or fungal infections in acute liver failure patients from India. Dig Dis Sci. 2023;68:4022–38.PubMedCrossRef
124.
Zurück zum Zitat Karvellas CJ, Cavazos J, Battenhouse H, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12:1942-9. e1. Karvellas CJ, Cavazos J, Battenhouse H, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12:1942-9. e1.
125.
Zurück zum Zitat Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64.PubMedCrossRef Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64.PubMedCrossRef
126.
Zurück zum Zitat Church DL, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev. 2020;33:e00053-19. Church DL, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev. 2020;33:e00053-19.
127.
Zurück zum Zitat Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75 Suppl 1:S101-s17. Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75 Suppl 1:S101-s17.
128.
Zurück zum Zitat Keighley C, Cooley L, Morris AJ, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J. 2021;51Suppl 7:89–117.PubMedCrossRef Keighley C, Cooley L, Morris AJ, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J. 2021;51Suppl 7:89–117.PubMedCrossRef
129.
Zurück zum Zitat Douglas AP, Smibert OC, Bajel A, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51Suppl 7:143–76.PubMedCrossRef Douglas AP, Smibert OC, Bajel A, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51Suppl 7:143–76.PubMedCrossRef
130.
131.
Zurück zum Zitat Hsu AJ, Tamma PD, Zhang SX. Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 2021;59:e0327620. Hsu AJ, Tamma PD, Zhang SX. Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 2021;59:e0327620.
132.
Zurück zum Zitat Ferrarese A, Cattelan A, Cillo U, et al. Invasive fungal infection before and after liver transplantation. World J Gastroenterol. 2020;26:7485–96.PubMedPubMedCentralCrossRef Ferrarese A, Cattelan A, Cillo U, et al. Invasive fungal infection before and after liver transplantation. World J Gastroenterol. 2020;26:7485–96.PubMedPubMedCentralCrossRef
133.
Zurück zum Zitat Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101:811–20.PubMedPubMedCentralCrossRef Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101:811–20.PubMedPubMedCentralCrossRef
134.
Zurück zum Zitat Stravitz RT, Fontana RJ, Meinzer C, et al. Coagulopathy, bleeding events, and outcome according to rotational thromboelastometry in patients with acute liver injury/failure. Hepatology. 2021;74:937–49.PubMedCrossRef Stravitz RT, Fontana RJ, Meinzer C, et al. Coagulopathy, bleeding events, and outcome according to rotational thromboelastometry in patients with acute liver injury/failure. Hepatology. 2021;74:937–49.PubMedCrossRef
135.
Zurück zum Zitat Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 2012;10:1312–9.PubMedCrossRef Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 2012;10:1312–9.PubMedCrossRef
137.
Zurück zum Zitat Ozbay Hosnut F, Ozcay F, Selda Bayrakci U, Avci Z, Özbek N. Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia. Eur J Pedia. 2008;167:1435–9.CrossRef Ozbay Hosnut F, Ozcay F, Selda Bayrakci U, Avci Z, Özbek N. Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia. Eur J Pedia. 2008;167:1435–9.CrossRef
138.
Zurück zum Zitat Bhutra A, Giri PP, Ganguly N. Acute hepatic failure with hemolytic anemia due to hepatitis A infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Pediat Infectious Dis. 2015;7:50–2.CrossRef Bhutra A, Giri PP, Ganguly N. Acute hepatic failure with hemolytic anemia due to hepatitis A infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Pediat Infectious Dis. 2015;7:50–2.CrossRef
139.
Zurück zum Zitat Premkumar M, Kulkarni AV, Kajal K, Divyaveer S. Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure. J Clin Exp Hepatol. 2022;12:533–43.PubMedCrossRef Premkumar M, Kulkarni AV, Kajal K, Divyaveer S. Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure. J Clin Exp Hepatol. 2022;12:533–43.PubMedCrossRef
140.
Zurück zum Zitat Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.PubMedCrossRef Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.PubMedCrossRef
141.
Zurück zum Zitat Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54. Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54.
142.
Zurück zum Zitat Goel A, Zachariah U, Daniel D, Eapen CE. Growing evidence for survival benefit with plasma exchange to treat liver failure. J Clin Exp Hepatol. 2023;13:1061–73.PubMedCrossRef Goel A, Zachariah U, Daniel D, Eapen CE. Growing evidence for survival benefit with plasma exchange to treat liver failure. J Clin Exp Hepatol. 2023;13:1061–73.PubMedCrossRef
143.
Zurück zum Zitat Thomas L, Chandran J, Goel A, et al. Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity. J Clin Exp Hepatol. 2023;13:252–8.PubMedCrossRef Thomas L, Chandran J, Goel A, et al. Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity. J Clin Exp Hepatol. 2023;13:252–8.PubMedCrossRef
144.
Zurück zum Zitat Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol. 1995;7:887–92.PubMed Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol. 1995;7:887–92.PubMed
145.
Zurück zum Zitat Govindarajan R, Ramamoorthy G, Shanmugam RM, et al. Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India. Indian J Gastroenterol. 2021;40:373–9.PubMedCrossRef Govindarajan R, Ramamoorthy G, Shanmugam RM, et al. Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India. Indian J Gastroenterol. 2021;40:373–9.PubMedCrossRef
146.
Zurück zum Zitat O’Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet. 1980;2 pt 1:615–7. O’Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet. 1980;2 pt 1:615–7.
148.
149.
Zurück zum Zitat Blot SI, Poelaert J, Kollef M. How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients. BMC Infect Dis. 2014;14:119. Blot SI, Poelaert J, Kollef M. How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients. BMC Infect Dis. 2014;14:119.
150.
Zurück zum Zitat Chase RA, Davies M, Trewby PN, Silk DB, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology. 1978;75:1033–40.PubMedCrossRef Chase RA, Davies M, Trewby PN, Silk DB, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology. 1978;75:1033–40.PubMedCrossRef
151.
Zurück zum Zitat Mallick S, Nair K, Thillai M, et al. Liver transplant in acute liver failure - looking back over 10 years. J Clin Exp Hepatol. 2020;10:322–8.PubMedCrossRef Mallick S, Nair K, Thillai M, et al. Liver transplant in acute liver failure - looking back over 10 years. J Clin Exp Hepatol. 2020;10:322–8.PubMedCrossRef
152.
Zurück zum Zitat Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 2018;37:25–30.PubMedCrossRef Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 2018;37:25–30.PubMedCrossRef
153.
Zurück zum Zitat Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408–21.PubMedCrossRef Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408–21.PubMedCrossRef
Metadaten
Titel
Critical care management of acute liver failure
verfasst von
Surender Singh Sehrawat
Madhumita Premkumar
Publikationsdatum
05.04.2024
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01556-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.